Todd E. Pesavento
YOU?
Author Swipe
View article: Real‐world experience in treatment of donor‐derived Hepatitis C virus in kidney transplant recipients with delayed initiation, shortened course glecaprevir/pibrentasvir versus standard of care
Real‐world experience in treatment of donor‐derived Hepatitis C virus in kidney transplant recipients with delayed initiation, shortened course glecaprevir/pibrentasvir versus standard of care Open
Background There is limited literature describing the real‐world practice of delayed initiation and shortened duration direct‐acting antiviral (DAA) in kidney transplant recipients. We compared Hepatitis C virus (HCV) cure rates among kidn…
View article: A single‐center review of outcomes between COVID‐19 vaccinated and unvaccinated liver transplant recipients
A single‐center review of outcomes between COVID‐19 vaccinated and unvaccinated liver transplant recipients Open
Background With the availability of vaccines against SARS‐COV‐2, recommendations for vaccination of transplant candidates are widespread. At our institution, patients may receive liver transplant (LTx) regardless of vaccine status. The pur…
View article: Comparison of outcomes in vaccinated versus unvaccinated COVID‐19 kidney transplant recipients, a single center retrospective study—Is the taboo justified?
Comparison of outcomes in vaccinated versus unvaccinated COVID‐19 kidney transplant recipients, a single center retrospective study—Is the taboo justified? Open
Introduction We assessed differences in the post‐transplant outcomes between COVID‐19 vaccinated and unvaccinated Kidney transplant (KTx) recipients. Methods We conducted a retrospective, single‐center study of 400 KTx from 2/1/2021 to 4/3…
View article: A Single-Center Case Series of Successful Abdominal Organ Transplantation From SARS-CoV-2–infected Donors to Uninfected Recipients—Do We Need Rigorous Monitoring?
A Single-Center Case Series of Successful Abdominal Organ Transplantation From SARS-CoV-2–infected Donors to Uninfected Recipients—Do We Need Rigorous Monitoring? Open
Background. There is limited documentation of hematogenous transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in non–lung transplants from infected donors to uninfected recipients. Methods. We analyzed 16 recipien…
View article: Survey of Salary and Job Satisfaction of Transplant Nephrologists in the United States
Survey of Salary and Job Satisfaction of Transplant Nephrologists in the United States Open
Background and objectives There are no standardized benchmarks to measure productivity and compensation of transplant nephrologists in the United States, and consequently, criteria set for general nephrologists are often used. Design, sett…
View article: Rare oral lesions from cytomegalovirus in kidney transplant
Rare oral lesions from cytomegalovirus in kidney transplant Open
A 47-year-old man with a history of deceased donor kidney transplant in May 2019 was admitted with odynophagia, pancytopaenia and neutropaenic fever. He had new tongue lesions ongoing for 2 weeks. Examination showed a 3×3 cm elevated, adhe…
View article: Transplant administration—A survey of the roles and responsibilities of kidney and pancreas medical directors of US transplant centers
Transplant administration—A survey of the roles and responsibilities of kidney and pancreas medical directors of US transplant centers Open
The current American Society of Transplantation (AST) accredited transplant fellowship programs in the United States provide no structured formal training in leadership and administration which is essential for successfully running a trans…
View article: Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial
Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial Open
Kidney transplant recipients, like other patients with chronic kidney disease (CKD), experience excess risk of cardiovascular disease (CVD) and elevated total homocysteine (tHcy) concentrations. Observational studies of patients with CKD s…
View article: Largest Experience of Safety and Efficacy of Patiromer in Solid Organ Transplant
Largest Experience of Safety and Efficacy of Patiromer in Solid Organ Transplant Open
Supplemental Digital Content is available in the text.
View article: Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort
Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort Open
Mild hyperphosphatemia is a putative risk factor for cardiovascular disease [CVD], loss of kidney function, and mortality. Very limited data are available from sizable multicenter kidney transplant recipient (KTR) cohorts assessing the pot…
View article: Expanding the use of HCV infected organs and the challenge of third-party payers
Expanding the use of HCV infected organs and the challenge of third-party payers Open
Expanding the
View article: Comparison of the glucagon‐like‐peptide‐1 receptor agonists dulaglutide and liraglutide for the management of diabetes in solid organ transplant: A retrospective study
Comparison of the glucagon‐like‐peptide‐1 receptor agonists dulaglutide and liraglutide for the management of diabetes in solid organ transplant: A retrospective study Open
Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are gaining popularity in the management of diabetes in solid organ transplant (SOT) recipients. There are no studies available comparing the two GLP‐1RAs dulaglutide and liraglutide in …
View article: Chronic mesenteric ischaemia masked by candida esophagitis in a renal transplant patient
Chronic mesenteric ischaemia masked by candida esophagitis in a renal transplant patient Open
Chronic mesenteric ischaemia is a severe disease that is often missed due to its non-specific presentation. Immunosuppressed patients are at risk for infectious gastrointestinal disease, which may further obscure the diagnosis of chronic m…
View article: Successful Treatment and Five Years of Disease-free Survival in a Donor Transmitted Metastatic Melanoma with Ipilimumab Therapy
Successful Treatment and Five Years of Disease-free Survival in a Donor Transmitted Metastatic Melanoma with Ipilimumab Therapy Open
Approximately 7% of deceased donors have unknown cancer at the time of organ procurement. More than half of these have no apparent contraindication to organ donation. The commonest transmitted malignancy is renal cell cancer (19%), followe…
View article: SUN-165 The Largest Single-Center Experience of GLP-1 Receptor Agonists as a Safe and Effective Agent for the Management of Diabetes in Solid Organ Transplant (SOT) Recipients
SUN-165 The Largest Single-Center Experience of GLP-1 Receptor Agonists as a Safe and Effective Agent for the Management of Diabetes in Solid Organ Transplant (SOT) Recipients Open
Background Post-transplant diabetes mellitus is a well-recognized complication of SOT. There is a limited published data regarding the approach to management. We aim to test the efficacy and safety of a GLP-1 analog, dulaglutide, an incret…
View article: Impact of Navigators on First Visit to a Transplant Center, Waitlisting, and Kidney Transplantation
Impact of Navigators on First Visit to a Transplant Center, Waitlisting, and Kidney Transplantation Open
Background and objectives Many patients with ESKD face barriers in completing the steps required to obtain a transplant. These eight sequential steps are medical suitability, interest in transplant, referral to a transplant center, first v…